Group One Trading, L.P. Spruce Biosciences, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 1,153 shares of SPRB stock, worth $69. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,153
Previous 1,769
34.82%
Holding current value
$69
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SPRB
# of Institutions
32Shares Held
15.2MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$176,17620.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$173,7911.04% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$156,5470.05% of portfolio
-
Abingworth LLP London, X01.79MShares$107,5510.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$62,7490.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $1.41M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...